Superworth

Bruker price to sales ratio BRKR

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026
2.5×
10-year median
3.2×
Against its 10-year history
20th
percentile: 0 is its lowest day, 100 its highest
10-year range
1.3× to 6.1×
Peer median
6.4×

Bruker's price to sales ratio is 2.5× as of Oct 23, 2026.

That is below its ten-year median of 3.2×, lower than on 80% of days in the last ten years.

Over that time it ranged from 1.3× in Aug 2025 to 6.1× in Sep 2021.

The median for 10 diagnostics and research stocks of a similar size is 6.4×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.5×1.5×2.8×
20252.1×1.3×2.8×
20242.7×2.4×4.4×
20233.6×2.8×4.9×
20224.0×3.0×4.8×
20215.4×4.4×6.1×
20204.2×2.5×4.3×
20193.9×2.4×4.2×
20182.4×2.2×3.3×
20173.1×2.2×3.2×
20162.1×2.0×2.9×
20152.5×1.7×2.5×
20141.8×1.6×2.2×
20131.9×1.5×1.9×
20121.4×1.1×1.6×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bruker's size, closest first, today.

CompanyPrice to sales ratio
BRKRBruker2.5×
CAICaris Life Sciences9.1×
BIOBio-Rad Laboratories3.8×
LNTHLantheus4.2×
BLLNBillionToOne12.8×
RVTYRevvity6.1×
MEDPMedpace6.7×
VCYTVeracyte6.9×
CDNACareDx7.8×
LHLabcorp1.9×
DGXQuest Diagnostics2.3×
Peer median6.4×

Where Bruker ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Bruker

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.